Summary
The primary purpose of the study is to assess how well amivantamab subcutaneous (SC)
administration in combination with lazertinib or in combination with chemotherapy works
(antitumor activity) in participants with epidermal growth factor receptor mutated
(EGFRm) non-small cell lung cancer (NSCLC; that is one of the major types of lung
cancer).
Treatment Sites in Georgia
Piedmont Cancer Institute – Locust Grove
4877 Bill Gardner Pkwy
Locust Grove, GA 30248
Piedmont Cancer Institute – Sandy Springs
Piedmont Cancer Institute – Sandy Springs
755 Mount Vernon Hwy
Suite 320
Atlanta, GA 30328